• 05.12.2019 – 09:42

  Mindtree

  Mindtree Wins SAFA Best Presented Annual Report Award

  Warren, New Jersey and Bangalore, India (ots/PRNewswire) - Company Recognized in 'Communication and Information Technology Sector' Category Mindtree, a global technology services and digital transformation company, has received a prestigious award from South Asian Federation of Accountants (SAFA) as a mark of recognition of its strong ethics, excellence in financial reporting and corporate governance. The company won the ...

  more

• 16.10.2019 – 08:46

  eROCKIT Systems GmbH

  

  5

  eROCKIT meets India: Diplomatic visit to German e-Mobility Startup

  more

  eROCKIT Newsroom

• 02.10.2019 – 10:48

  OPTIMA packaging group GmbH

  

  5

  OPTIMA looks back at a successful FachPack 2019

  more

  One document

• 27.09.2019 – 08:01

  Merck KGaA

  Abstracts highlight data on BAVENCIO as a monotherapy and in combination in multiple advanced cancers

  Darmstadt, Germany, and New York (ots/PRNewswire) - Not intended for US, Canada and UK-based media Merck and Pfizer Inc. (NYSE: PFE) today announced the presentation of multiple analyses from the JAVELIN clinical development program assessing BAVENCIO® (avelumab) alone or as part of combination regimens for the ...

  more

• 09.07.2019 – 15:09

  OPTIMA packaging group GmbH

  

  OPTIMA is breaking new ground at FachPack 2019

  more

  One document

• 27.05.2019 – 12:53

  nova-Institut GmbH

  

  PRESS RELEASE: Six candidates nominated for the innovation award "Hemp Product of the Year 2019"

  more

  Subscribe to nova's mailing lists

• 21.03.2019 – 14:35

  nova-Institut GmbH

  

  PRESS RELEASE / PRESSEMITTEILUNG: Winners of innovation award "Best CO2 Utilisation 2019"

  more

  Subscribe to nova's mailing list

• 10.12.2018 – 16:21

  Merck KGaA

  Merck Announces FDA Orphan Drug Designation for Bifunctional Immunotherapy M7824 in Biliary Tract Cancer

  Darmstadt, Germany (ots/PRNewswire) - The information contained is not intended for distribution in the USA, Canada or the UK - FDA grants M7824, an investigational bifunctional immunotherapy, orphan drug designation in biliary tract cancer - First regulatory designation for M7824 following recent presentation of ...

  more

• 06.08.2018 – 09:01

  Daiichi Sankyo Europe GmbH

  New Analysis Identifies Patient Populations With Cancer-associated VTE Who Could Benefit From Treatment With Oral, Once-daily LIXIANA® (edoxaban)

  Munich (ots/PRNewswire) - - Hokusai-VTE CANCER study showed that oral edoxaban is non-inferior to subcutaneous injectable dalteparin, for the composite outcome of recurrent venous thromboembolism (VTE) and major bleeding in cancer-associated VTE - This analysis provides benefit/risk assessment in different types of ...

  more